More Information
Summary:Abstract The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said 5 compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Bibliography:Application Number: AU20170202512